RISA KAGAN
- Type
- Physician · Allopathic & Osteopathic Physicians / Obstetrics & Gynecology
- Where
- BERKELEY, CA
- NPI
- 1336255660
- Received
- $503,208 in 464 records, 2019 to 2025 ($496,517 general, $6,691 research)
- As principal investigator
- $10,274 of research payments to others in 6 records
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 100 | $116,603 |
| 2024 | General payment | 78 | $99,668 |
| 2023 | General payment | 87 | $105,804 |
| 2023 | Research payment | 5 | $3,162 |
| 2022 | General payment | 21 | $44,980 |
| 2021 | General payment | 5 | $2,570 |
| 2021 | Research payment | 1 | $189 |
| 2020 | General payment | 19 | $29,260 |
| 2020 | Research payment | 1 | $3,339 |
| 2019 | General payment | 147 | $97,629 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| Astellas Pharma US Inc | 157 | $188,096 | 2019–2025 |
| TherapeuticsMD, Inc. | 90 | $59,817 | 2019–2021 |
| Astellas Pharma Europe Ltd | 39 | $51,567 | 2024–2025 |
| MAYNE PHARMA COMMERCIAL LLC | 43 | $50,361 | 2024–2025 |
| PFIZER INC. | 30 | $49,185 | 2022–2024 |
| AMAG Pharmaceuticals, Inc. | 30 | $26,534 | 2019–2020 |
| CooperSurgical, Inc. | 20 | $23,165 | 2019–2022 |
| PFIZER INTERNATIONAL LLC | 4 | $16,937 | 2022 |
| Astellas Pharma Global Development | 13 | $10,394 | 2023–2025 |
| Amgen Inc. | 11 | $7,419 | 2019–2021 |
| Lupin Inc. | 1 | $5,777 | 2020 |
| Exeltis, USA Inc. | 2 | $3,697 | 2024 |
| SCYNEXIS, Inc. | 3 | $3,269 | 2021–2022 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $2,977 | 2023–2025 |
| JAZZ PHARMACEUTICALS INC. | 2 | $1,604 | 2020 |
| Heron Therapeutics, Inc. | 1 | $1,500 | 2019 |
| Novo Nordisk Inc | 4 | $375 | 2023–2024 |
| Radius Health, Inc. | 2 | $225 | 2019 |
| ABBVIE INC. | 4 | $149 | 2019–2020 |
| Sumitomo Pharma America, Inc. | 2 | $127 | 2023 |
| Avion Pharmaceuticals | 1 | $27 | 2022 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 101 | $268,562 |
| Consulting Fee | 47 | $134,763 |
| Travel and Lodging | 140 | $62,239 |
| Honoraria | 4 | $16,975 |
| Food and Beverage | 157 | $13,581 |
| Research payment | 7 | $6,691 |
| Education | 8 | $395 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-15 | Astellas Pharma Europe Ltd | $2,700 | Consulting Fee | Cash or cash equivalent | Veozah Drug, Biological | 2025 | |
| 2025-12-11 | MAYNE PHARMA COMMERCIAL LLC | $5,400 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | BIJUVA Drug, MENOPAUSE | 2025 | |
| 2025-12-11 | MAYNE PHARMA COMMERCIAL LLC | $344 | Travel and Lodging | In-kind items and services | BIJUVA Drug, MENOPAUSE | 2025 | |
| 2025-12-11 | MAYNE PHARMA COMMERCIAL LLC | $314 | Food and Beverage | Cash or cash equivalent | BIJUVA Drug, MENOPAUSE | 2025 | |
| 2025-12-11 | MAYNE PHARMA COMMERCIAL LLC | $259 | Travel and Lodging | In-kind items and services | BIJUVA Drug, MENOPAUSE | 2025 | |
| 2025-12-11 | MAYNE PHARMA COMMERCIAL LLC | $121 | Food and Beverage | In-kind items and services | BIJUVA Drug, MENOPAUSE | 2025 | |
| 2025-11-20 | MAYNE PHARMA COMMERCIAL LLC | $3,240 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | BIJUVA Drug, MENOPAUSE | 2025 | |
| 2025-11-20 | MAYNE PHARMA COMMERCIAL LLC | $1,194 | Travel and Lodging | In-kind items and services | BIJUVA Drug, MENOPAUSE | 2025 | |
| 2025-11-20 | MAYNE PHARMA COMMERCIAL LLC | $490 | Travel and Lodging | In-kind items and services | BIJUVA Drug, MENOPAUSE | 2025 | |
| 2025-11-20 | MAYNE PHARMA COMMERCIAL LLC | $214 | Travel and Lodging | In-kind items and services | BIJUVA Drug, MENOPAUSE | 2025 | |
| 2025-11-20 | MAYNE PHARMA COMMERCIAL LLC | $155 | Food and Beverage | Cash or cash equivalent | BIJUVA Drug, MENOPAUSE | 2025 | |
| 2025-11-20 | MAYNE PHARMA COMMERCIAL LLC | $124 | Food and Beverage | In-kind items and services | BIJUVA Drug, MENOPAUSE | 2025 | |
| 2025-11-19 | MAYNE PHARMA COMMERCIAL LLC | $5,400 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | BIJUVA Drug, MENOPAUSE | 2025 | |
| 2025-11-19 | MAYNE PHARMA COMMERCIAL LLC | $490 | Travel and Lodging | In-kind items and services | BIJUVA Drug, MENOPAUSE | 2025 | |
| 2025-11-19 | MAYNE PHARMA COMMERCIAL LLC | $214 | Travel and Lodging | In-kind items and services | BIJUVA Drug, MENOPAUSE | 2025 | |
| 2025-11-19 | MAYNE PHARMA COMMERCIAL LLC | $152 | Food and Beverage | Cash or cash equivalent | BIJUVA Drug, MENOPAUSE | 2025 | |
| 2025-11-19 | MAYNE PHARMA COMMERCIAL LLC | $108 | Food and Beverage | In-kind items and services | BIJUVA Drug, MENOPAUSE | 2025 | |
| 2025-11-12 | Astellas Pharma US Inc | $4,125 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Veozah Drug, Biological | 2025 | |
| 2025-11-12 | Astellas Pharma US Inc | $127 | Food and Beverage | In-kind items and services | Veozah Drug, Biological | 2025 | |
| 2025-11-05 | MAYNE PHARMA COMMERCIAL LLC | $5,400 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | BIJUVA Drug, MENOPAUSE | 2025 | |
| 2025-11-05 | MAYNE PHARMA COMMERCIAL LLC | $417 | Travel and Lodging | In-kind items and services | BIJUVA Drug, MENOPAUSE | 2025 | |
| 2025-11-05 | MAYNE PHARMA COMMERCIAL LLC | $263 | Travel and Lodging | In-kind items and services | BIJUVA Drug, MENOPAUSE | 2025 | |
| 2025-11-05 | MAYNE PHARMA COMMERCIAL LLC | $238 | Food and Beverage | Cash or cash equivalent | BIJUVA Drug, MENOPAUSE | 2025 | |
| 2025-10-30 | Astellas Pharma Global Development | $812 | Consulting Fee | Cash or cash equivalent | Veozah Drug, Biological | 2025 | |
| 2025-10-30 | Astellas Pharma US Inc | $585 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Veozah Drug, Biological | 2025 | |
| 2025-10-29 | Astellas Pharma US Inc | $4,950 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Veozah Drug, Biological | 2025 | |
| 2025-10-29 | Astellas Pharma US Inc | $888 | Travel and Lodging | Cash or cash equivalent | Veozah Drug, Biological | 2025 | |
| 2025-10-29 | Astellas Pharma US Inc | $87 | Food and Beverage | In-kind items and services | Veozah Drug, Biological | 2025 | |
| 2025-10-23 | Astellas Pharma US Inc | $127 | Food and Beverage | In-kind items and services | Veozah Drug, Biological | 2025 | |
| 2025-10-23 | Bayer Healthcare Pharmaceuticals Inc. | $114 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-09-24 | Astellas Pharma US Inc | $2,935 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Veozah Drug, Biological | 2025 | |
| 2025-09-24 | Astellas Pharma US Inc | $94 | Food and Beverage | In-kind items and services | Veozah Drug, Biological | 2025 | |
| 2025-09-10 | MAYNE PHARMA COMMERCIAL LLC | $5,400 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | BIJUVA Drug, MENOPAUSE | 2025 | |
| 2025-09-10 | MAYNE PHARMA COMMERCIAL LLC | $320 | Travel and Lodging | In-kind items and services | BIJUVA Drug, MENOPAUSE | 2025 | |
| 2025-09-10 | MAYNE PHARMA COMMERCIAL LLC | $242 | Food and Beverage | Cash or cash equivalent | BIJUVA Drug, MENOPAUSE | 2025 | |
| 2025-09-10 | MAYNE PHARMA COMMERCIAL LLC | $121 | Food and Beverage | In-kind items and services | BIJUVA Drug, MENOPAUSE | 2025 | |
| 2025-08-18 | Astellas Pharma Europe Ltd | $22,842 | Consulting Fee | Cash or cash equivalent | Veozah Drug, Biological | 2025 | |
| 2025-08-18 | Astellas Pharma Europe Ltd | $222 | Travel and Lodging | Cash or cash equivalent | Veozah Drug, Biological | 2025 | |
| 2025-08-18 | Astellas Pharma Europe Ltd | $32 | Food and Beverage | In-kind items and services | Veozah Drug, Biological | 2025 | |
| 2025-08-04 | Astellas Pharma US Inc | $325 | Consulting Fee | Cash or cash equivalent | Veozah Drug, Biological | 2025 | |
| 2025-07-31 | MAYNE PHARMA COMMERCIAL LLC | $3,240 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | BIJUVA Drug, MENOPAUSE | 2025 | |
| 2025-07-31 | MAYNE PHARMA COMMERCIAL LLC | $121 | Food and Beverage | In-kind items and services | BIJUVA Drug, MENOPAUSE | 2025 | |
| 2025-07-30 | Astellas Pharma Global Development | $18 | Food and Beverage | In-kind items and services | Veozah Drug, Biological | 2025 | |
| 2025-07-29 | Astellas Pharma US Inc | $2,935 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Veozah Drug, Biological | 2025 | |
| 2025-07-29 | Astellas Pharma US Inc | $783 | Travel and Lodging | Cash or cash equivalent | Veozah Drug, Biological | 2025 | |
| 2025-07-29 | Astellas Pharma US Inc | $90 | Food and Beverage | In-kind items and services | Veozah Drug, Biological | 2025 | |
| 2025-07-24 | MAYNE PHARMA COMMERCIAL LLC | $4,320 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | BIJUVA Drug, MENOPAUSE | 2025 | |
| 2025-07-24 | MAYNE PHARMA COMMERCIAL LLC | $1,375 | Travel and Lodging | In-kind items and services | BIJUVA Drug, MENOPAUSE | 2025 | |
| 2025-07-24 | MAYNE PHARMA COMMERCIAL LLC | $104 | Food and Beverage | In-kind items and services | BIJUVA Drug, MENOPAUSE | 2025 | |
| 2025-07-16 | Astellas Pharma US Inc | $880 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Veozah Drug, Biological | 2025 | |
| 2025-07-16 | Astellas Pharma US Inc | $585 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Veozah Drug, Biological | 2025 | |
| 2025-07-08 | Astellas Pharma US Inc | $5 | Food and Beverage | In-kind items and services | Veozah Drug, Biological | 2025 | |
| 2025-06-12 | MAYNE PHARMA COMMERCIAL LLC | $5,400 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | BIJUVA Drug, MENOPAUSE | 2025 | |
| 2025-06-12 | MAYNE PHARMA COMMERCIAL LLC | $585 | Travel and Lodging | In-kind items and services | BIJUVA Drug, MENOPAUSE | 2025 | |
| 2025-06-12 | MAYNE PHARMA COMMERCIAL LLC | $137 | Travel and Lodging | In-kind items and services | BIJUVA Drug, MENOPAUSE | 2025 | |
| 2025-06-12 | MAYNE PHARMA COMMERCIAL LLC | $123 | Food and Beverage | In-kind items and services | BIJUVA Drug, MENOPAUSE | 2025 | |
| 2025-06-12 | MAYNE PHARMA COMMERCIAL LLC | $81 | Food and Beverage | Cash or cash equivalent | BIJUVA Drug, MENOPAUSE | 2025 | |
| 2025-06-08 | Astellas Pharma Europe Ltd | $300 | Travel and Lodging | Cash or cash equivalent | Veozah Drug, Biological | 2025 | |
| 2025-06-08 | Astellas Pharma Europe Ltd | $268 | Travel and Lodging | Cash or cash equivalent | Veozah Drug, Biological | 2025 | |
| 2025-06-08 | Astellas Pharma Europe Ltd | $41 | Food and Beverage | In-kind items and services | Veozah Drug, Biological | 2025 | |
| 2025-06-08 | Astellas Pharma Europe Ltd | $35 | Food and Beverage | In-kind items and services | Veozah Drug, Biological | 2025 | |
| 2025-06-08 | Astellas Pharma Europe Ltd | $17 | Food and Beverage | In-kind items and services | Veozah Drug, Biological | 2025 | |
| 2025-06-07 | Astellas Pharma Europe Ltd | $300 | Travel and Lodging | Cash or cash equivalent | Veozah Drug, Biological | 2025 | |
| 2025-06-07 | Astellas Pharma Europe Ltd | $41 | Food and Beverage | In-kind items and services | Veozah Drug, Biological | 2025 | |
| 2025-06-07 | Astellas Pharma Europe Ltd | $35 | Food and Beverage | In-kind items and services | Veozah Drug, Biological | 2025 | |
| 2025-06-07 | Astellas Pharma Europe Ltd | $17 | Food and Beverage | In-kind items and services | Veozah Drug, Biological | 2025 | |
| 2025-06-07 | Astellas Pharma Europe Ltd | $17 | Food and Beverage | In-kind items and services | Veozah Drug, Biological | 2025 | |
| 2025-06-07 | Astellas Pharma Europe Ltd | $2 | Food and Beverage | In-kind items and services | Veozah Drug, Biological | 2025 | |
| 2025-06-06 | Astellas Pharma Europe Ltd | $300 | Travel and Lodging | Cash or cash equivalent | Veozah Drug, Biological | 2025 | |
| 2025-06-06 | Astellas Pharma Europe Ltd | $75 | Food and Beverage | In-kind items and services | Veozah Drug, Biological | 2025 | |
| 2025-06-06 | Astellas Pharma Europe Ltd | $41 | Food and Beverage | In-kind items and services | Veozah Drug, Biological | 2025 | |
| 2025-06-06 | Astellas Pharma Europe Ltd | $1 | Food and Beverage | In-kind items and services | Veozah Drug, Biological | 2025 | |
| 2025-06-05 | Astellas Pharma Europe Ltd | $692 | Travel and Lodging | Cash or cash equivalent | Veozah Drug, Biological | 2025 | |
| 2025-06-05 | Astellas Pharma Europe Ltd | $268 | Travel and Lodging | Cash or cash equivalent | Veozah Drug, Biological | 2025 | |
| 2025-04-25 | Astellas Pharma Global Development | $650 | Consulting Fee | Cash or cash equivalent | Veozah Drug, Biological | 2025 | |
| 2025-04-02 | Astellas Pharma US Inc | $3,520 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Veozah Drug, Biological | 2025 | |
| 2025-04-02 | Astellas Pharma US Inc | $676 | Travel and Lodging | Cash or cash equivalent | Veozah Drug, Biological | 2025 | |
| 2025-04-02 | Astellas Pharma US Inc | $238 | Travel and Lodging | Cash or cash equivalent | Veozah Drug, Biological | 2025 | |
| 2025-04-02 | Astellas Pharma US Inc | $222 | Travel and Lodging | Cash or cash equivalent | Veozah Drug, Biological | 2025 | |
| 2025-04-02 | Astellas Pharma US Inc | $99 | Food and Beverage | In-kind items and services | Veozah Drug, Biological | 2025 | |
| 2025-03-22 | MAYNE PHARMA COMMERCIAL LLC | $2,565 | Honoraria | Cash or cash equivalent | BIJUVA Drug, MENOPAUSE | 2025 | |
| 2025-03-22 | MAYNE PHARMA COMMERCIAL LLC | $692 | Travel and Lodging | In-kind items and services | BIJUVA Drug, MENOPAUSE | 2025 | |
| 2025-03-22 | MAYNE PHARMA COMMERCIAL LLC | $305 | Travel and Lodging | In-kind items and services | BIJUVA Drug, MENOPAUSE | 2025 | |
| 2025-03-22 | MAYNE PHARMA COMMERCIAL LLC | $181 | Travel and Lodging | In-kind items and services | BIJUVA Drug, MENOPAUSE | 2025 | |
| 2025-03-22 | MAYNE PHARMA COMMERCIAL LLC | $166 | Food and Beverage | Cash or cash equivalent | BIJUVA Drug, MENOPAUSE | 2025 | |
| 2025-03-22 | MAYNE PHARMA COMMERCIAL LLC | $67 | Food and Beverage | In-kind items and services | BIJUVA Drug, MENOPAUSE | 2025 | |
| 2025-03-22 | MAYNE PHARMA COMMERCIAL LLC | $48 | Food and Beverage | In-kind items and services | BIJUVA Drug, MENOPAUSE | 2025 | |
| 2025-03-21 | MAYNE PHARMA COMMERCIAL LLC | $124 | Food and Beverage | In-kind items and services | BIJUVA Drug, MENOPAUSE | 2025 | |
| 2025-03-20 | Bayer Healthcare Pharmaceuticals Inc. | $2,652 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-02-24 | Astellas Pharma Europe Ltd | $650 | Consulting Fee | Cash or cash equivalent | Veozah Drug, Biological | 2025 | |
| 2025-02-11 | Astellas Pharma US Inc | $2,935 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Veozah Drug, Biological | 2025 | |
| 2025-02-11 | Astellas Pharma US Inc | $169 | Travel and Lodging | Cash or cash equivalent | Veozah Drug, Biological | 2025 | |
| 2025-02-11 | Astellas Pharma US Inc | $140 | Food and Beverage | In-kind items and services | Veozah Drug, Biological | 2025 | |
| 2025-02-03 | Astellas Pharma US Inc | $585 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Veozah Drug, Biological | 2025 | |
| 2025-01-30 | Astellas Pharma US Inc | $3,520 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Veozah Drug, Biological | 2025 | |
| 2025-01-30 | Astellas Pharma US Inc | $783 | Travel and Lodging | Cash or cash equivalent | Veozah Drug, Biological | 2025 | |
| 2025-01-30 | Astellas Pharma US Inc | $124 | Food and Beverage | In-kind items and services | Veozah Drug, Biological | 2025 | |
| 2025-01-13 | Astellas Pharma US Inc | $585 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Veozah Drug, Biological | 2025 | |
| 2025-01-09 | Astellas Pharma Global Development | $41 | Food and Beverage | In-kind items and services | Veozah Drug, Biological | 2025 | |
| 2025-01-09 | Astellas Pharma Global Development | $14 | Food and Beverage | In-kind items and services | Veozah Drug, Biological | 2025 | |
| 2024-11-18 | Astellas Pharma Europe Ltd | $1,300 | Consulting Fee | Cash or cash equivalent | Veozah Drug, Biological | 2024 | |
| 2024-10-17 | Astellas Pharma US Inc | $3,520 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Veozah Drug, Biological | 2024 | |
| 2024-10-17 | Astellas Pharma US Inc | $371 | Travel and Lodging | Cash or cash equivalent | Veozah Drug, Biological | 2024 | |
| 2024-10-17 | Astellas Pharma US Inc | $206 | Travel and Lodging | Cash or cash equivalent | Veozah Drug, Biological | 2024 | |
| 2024-10-17 | Astellas Pharma US Inc | $180 | Travel and Lodging | Cash or cash equivalent | Veozah Drug, Biological | 2024 | |
| 2024-10-17 | Astellas Pharma US Inc | $125 | Food and Beverage | In-kind items and services | Veozah Drug, Biological | 2024 | |
| 2024-10-17 | Astellas Pharma US Inc | $12 | Food and Beverage | In-kind items and services | Veozah Drug, Biological | 2024 | |
| 2024-10-04 | Exeltis, USA Inc. | $3,638 | Consulting Fee | Cash or cash equivalent | SLYND Drug, CONTRACEPTIVE | 2024 | |
| 2024-09-13 | Astellas Pharma US Inc | $1,760 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Veozah Drug, Biological | 2024 | |
| 2024-09-12 | Astellas Pharma US Inc | $975 | Consulting Fee | Cash or cash equivalent | Veozah Drug, Biological | 2024 | |
| 2024-09-12 | Bayer Healthcare Pharmaceuticals Inc. | $100 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-09-12 | Novo Nordisk Inc | $52 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-09-12 | Bayer Healthcare Pharmaceuticals Inc. | $44 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-09-10 | Novo Nordisk Inc | $162 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-09-09 | Exeltis, USA Inc. | $58 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-09-06 | Novo Nordisk Inc | $30 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-08-30 | PFIZER INC. | $5,850 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2024 | ||
| 2024-08-29 | PFIZER INC. | $215 | Travel and Lodging | In-kind items and services | 2024 | ||
| 2024-08-05 | Astellas Pharma Europe Ltd | $1,950 | Consulting Fee | Cash or cash equivalent | Veozah Drug, Biological | 2024 | |
| 2024-08-01 | PFIZER INC. | $6,660 | Honoraria | Cash or cash equivalent | DUAVEE Drug, GENITOURINARY (SEXUAL HEALTH);WOMENS HEALTH | 2024 | |
| 2024-07-26 | PFIZER INC. | $825 | Travel and Lodging | In-kind items and services | DUAVEE Drug, GENITOURINARY (SEXUAL HEALTH);WOMENS HEALTH | 2024 | |
| 2024-07-26 | PFIZER INC. | $406 | Travel and Lodging | In-kind items and services | DUAVEE Drug, GENITOURINARY (SEXUAL HEALTH);WOMENS HEALTH | 2024 | |
| 2024-07-26 | PFIZER INC. | $351 | Travel and Lodging | In-kind items and services | DUAVEE Drug, GENITOURINARY (SEXUAL HEALTH);WOMENS HEALTH | 2024 | |
| 2024-07-24 | Astellas Pharma Global Development | $2,762 | Consulting Fee | Cash or cash equivalent | Veozah Drug, Biological | 2024 | |
| 2024-06-25 | PFIZER INC. | $61 | Travel and Lodging | Cash or cash equivalent | DUAVEE Drug, GENITOURINARY (SEXUAL HEALTH);WOMENS HEALTH | 2024 | |
| 2024-05-30 | Astellas Pharma US Inc | $3,520 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Veozah Drug, Biological | 2024 | |
| 2024-05-30 | Astellas Pharma US Inc | $891 | Travel and Lodging | Cash or cash equivalent | Veozah Drug, Biological | 2024 | |
| 2024-05-30 | Astellas Pharma US Inc | $112 | Food and Beverage | In-kind items and services | Veozah Drug, Biological | 2024 | |
| 2024-05-24 | Astellas Pharma US Inc | $650 | Consulting Fee | Cash or cash equivalent | Veozah Drug, Biological | 2024 | |
| 2024-05-22 | Astellas Pharma US Inc | $3,520 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Veozah Drug, Biological | 2024 | |
| 2024-05-22 | Astellas Pharma US Inc | $1,124 | Travel and Lodging | Cash or cash equivalent | Veozah Drug, Biological | 2024 | |
| 2024-05-22 | Astellas Pharma US Inc | $55 | Food and Beverage | In-kind items and services | Veozah Drug, Biological | 2024 | |
| 2024-05-17 | Astellas Pharma US Inc | $1,760 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Veozah Drug, Biological | 2024 | |
| 2024-05-17 | PFIZER INC. | $245 | Travel and Lodging | In-kind items and services | DUAVEE Drug, GENITOURINARY (SEXUAL HEALTH);WOMENS HEALTH | 2024 | |
| 2024-05-17 | MAYNE PHARMA COMMERCIAL LLC | $88 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-05-17 | Astellas Pharma US Inc | $61 | Travel and Lodging | Cash or cash equivalent | Veozah Drug, Biological | 2024 | |
| 2024-04-18 | Astellas Pharma US Inc | $3,520 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Veozah Drug, Biological | 2024 | |
| 2024-04-18 | Astellas Pharma US Inc | $971 | Travel and Lodging | Cash or cash equivalent | Veozah Drug, Biological | 2024 | |
| 2024-04-18 | Astellas Pharma US Inc | $107 | Food and Beverage | In-kind items and services | Veozah Drug, Biological | 2024 | |
| 2024-04-17 | Astellas Pharma US Inc | $3,520 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Veozah Drug, Biological | 2024 | |
| 2024-04-17 | Astellas Pharma US Inc | $534 | Travel and Lodging | Cash or cash equivalent | Veozah Drug, Biological | 2024 | |
| 2024-04-17 | Astellas Pharma US Inc | $267 | Travel and Lodging | Cash or cash equivalent | Veozah Drug, Biological | 2024 | |
| 2024-04-17 | Astellas Pharma US Inc | $174 | Travel and Lodging | Cash or cash equivalent | Veozah Drug, Biological | 2024 | |
| 2024-04-17 | Astellas Pharma US Inc | $98 | Food and Beverage | In-kind items and services | Veozah Drug, Biological | 2024 | |
| 2024-04-04 | Astellas Pharma US Inc | $3,520 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Veozah Drug, Biological | 2024 | |
| 2024-04-04 | Astellas Pharma US Inc | $909 | Travel and Lodging | Cash or cash equivalent | Veozah Drug, Biological | 2024 | |
| 2024-04-04 | Astellas Pharma US Inc | $92 | Food and Beverage | In-kind items and services | Veozah Drug, Biological | 2024 | |
| 2024-03-15 | Astellas Pharma US Inc | $2,055 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Veozah Drug, Biological | 2024 | |
| 2024-03-13 | Astellas Pharma US Inc | $2,935 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Veozah Drug, Biological | 2024 | |
| 2024-03-13 | Astellas Pharma US Inc | $124 | Food and Beverage | In-kind items and services | Veozah Drug, Biological | 2024 | |
| 2024-03-06 | Astellas Pharma US Inc | $3,520 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Veozah Drug, Biological | 2024 | |
| 2024-03-06 | Astellas Pharma US Inc | $711 | Travel and Lodging | Cash or cash equivalent | Veozah Drug, Biological | 2024 | |
| 2024-03-06 | Astellas Pharma US Inc | $125 | Food and Beverage | In-kind items and services | Veozah Drug, Biological | 2024 | |
| 2024-02-26 | Astellas Pharma US Inc | $880 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Veozah Drug, Biological | 2024 | |
| 2024-02-22 | Astellas Pharma US Inc | $3,520 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Veozah Drug, Biological | 2024 | |
| 2024-02-22 | Astellas Pharma US Inc | $1,001 | Travel and Lodging | Cash or cash equivalent | Veozah Drug, Biological | 2024 | |
| 2024-02-22 | Astellas Pharma US Inc | $82 | Food and Beverage | In-kind items and services | Veozah Drug, Biological | 2024 | |
| 2024-02-12 | Astellas Pharma Europe Ltd | $10,400 | Consulting Fee | Cash or cash equivalent | Veozah Drug, Biological | 2024 | |
| 2024-02-12 | Astellas Pharma Europe Ltd | $221 | Travel and Lodging | Cash or cash equivalent | Veozah Drug, Biological | 2024 | |
| 2024-02-06 | Astellas Pharma US Inc | $2,935 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Veozah Drug, Biological | 2024 | |
| 2024-02-06 | Astellas Pharma US Inc | $153 | Travel and Lodging | Cash or cash equivalent | Veozah Drug, Biological | 2024 | |
| 2024-02-06 | Astellas Pharma US Inc | $125 | Food and Beverage | In-kind items and services | Veozah Drug, Biological | 2024 | |
| 2024-02-05 | PFIZER INC. | $7 | Food and Beverage | In-kind items and services | DUAVEE Drug, GENITOURINARY (SEXUAL HEALTH);WOMENS HEALTH | 2024 | |
| 2024-01-24 | Astellas Pharma US Inc | $2,112 | Consulting Fee | Cash or cash equivalent | Veozah Drug, Biological | 2024 | |
| 2024-01-14 | Astellas Pharma Europe Ltd | $659 | Travel and Lodging | Cash or cash equivalent | Veozah Drug, Biological | 2024 | |
| 2024-01-14 | Astellas Pharma Europe Ltd | $86 | Food and Beverage | In-kind items and services | Veozah Drug, Biological | 2024 | |
| 2024-01-13 | Astellas Pharma Europe Ltd | $40 | Food and Beverage | In-kind items and services | Veozah Drug, Biological | 2024 | |
| 2024-01-13 | Astellas Pharma Europe Ltd | $16 | Food and Beverage | In-kind items and services | Veozah Drug, Biological | 2024 | |
| 2024-01-13 | Astellas Pharma Europe Ltd | $8 | Food and Beverage | In-kind items and services | Veozah Drug, Biological | 2024 | |
| 2024-01-13 | Astellas Pharma Europe Ltd | $7 | Food and Beverage | In-kind items and services | Veozah Drug, Biological | 2024 | |
| 2024-01-12 | Astellas Pharma Europe Ltd | $66 | Food and Beverage | In-kind items and services | Veozah Drug, Biological | 2024 | |
| 2024-01-12 | Astellas Pharma Europe Ltd | $43 | Food and Beverage | In-kind items and services | Veozah Drug, Biological | 2024 | |
| 2024-01-12 | Astellas Pharma Europe Ltd | $31 | Travel and Lodging | Cash or cash equivalent | Veozah Drug, Biological | 2024 | |
| 2024-01-12 | Astellas Pharma Europe Ltd | $17 | Food and Beverage | In-kind items and services | Veozah Drug, Biological | 2024 | |
| 2024-01-12 | Astellas Pharma Europe Ltd | $8 | Food and Beverage | In-kind items and services | Veozah Drug, Biological | 2024 | |
| 2024-01-12 | Astellas Pharma Europe Ltd | $6 | Food and Beverage | In-kind items and services | Veozah Drug, Biological | 2024 | |
| 2024-01-10 | Astellas Pharma Europe Ltd | $7,800 | Travel and Lodging | Cash or cash equivalent | Veozah Drug, Biological | 2024 | |
| 2024-01-09 | Astellas Pharma US Inc | $2,600 | Consulting Fee | Cash or cash equivalent | Veozah Drug, Biological | 2024 | |
| 2023-12-22 | PFIZER INC. | $628 | Travel and Lodging | In-kind items and services | DUAVEE Drug, GENITOURINARY (SEXUAL HEALTH);WOMENS HEALTH | 2023 | |
| 2023-12-14 | PFIZER INC. | $30 | Travel and Lodging | In-kind items and services | 2023 | ||
| 2023-12-13 | Astellas Pharma US Inc | $2,055 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Veozah Drug, Biological | 2023 | |
| 2023-12-13 | Astellas Pharma US Inc | $22 | Travel and Lodging | Cash or cash equivalent | Veozah Drug, Biological | 2023 | |
| 2023-12-06 | Astellas Pharma US Inc | $2,055 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Veozah Drug, Biological | 2023 | |
| 2023-12-06 | Astellas Pharma US Inc | $1,175 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Veozah Drug, Biological | 2023 | |
| 2023-12-06 | Astellas Pharma US Inc | $125 | Food and Beverage | In-kind items and services | Veozah Drug, Biological | 2023 | |
| 2023-12-06 | Astellas Pharma US Inc | $33 | Food and Beverage | In-kind items and services | Veozah Drug, Biological | 2023 | |
| 2023-12-06 | Astellas Pharma US Inc | $14 | Travel and Lodging | Cash or cash equivalent | Veozah Drug, Biological | 2023 | |
| 2023-12-05 | Astellas Pharma US Inc | $2,055 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Veozah Drug, Biological | 2023 | |
| 2023-12-05 | Astellas Pharma US Inc | $1,457 | Travel and Lodging | Cash or cash equivalent | Veozah Drug, Biological | 2023 | |
| 2023-12-05 | Astellas Pharma US Inc | $1,175 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Veozah Drug, Biological | 2023 | |
| 2023-12-05 | Astellas Pharma US Inc | $223 | Travel and Lodging | Cash or cash equivalent | Veozah Drug, Biological | 2023 | |
| 2023-12-05 | Astellas Pharma US Inc | $86 | Food and Beverage | In-kind items and services | Veozah Drug, Biological | 2023 | |
| 2023-12-05 | Astellas Pharma US Inc | $49 | Food and Beverage | In-kind items and services | Veozah Drug, Biological | 2023 | |
| 2023-12-05 | Astellas Pharma US Inc | $15 | Travel and Lodging | Cash or cash equivalent | Veozah Drug, Biological | 2023 | |
| 2023-11-29 | Astellas Pharma US Inc | $2,935 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Veozah Drug, Biological | 2023 | |
| 2023-11-29 | Astellas Pharma US Inc | $843 | Travel and Lodging | Cash or cash equivalent | Veozah Drug, Biological | 2023 | |
| 2023-11-29 | Astellas Pharma US Inc | $54 | Food and Beverage | In-kind items and services | Veozah Drug, Biological | 2023 | |
| 2023-11-17 | Astellas Pharma US Inc | $880 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Veozah Drug, Biological | 2023 | |
| 2023-11-01 | PFIZER INC. | $8,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2023 | ||
| 2023-10-19 | PFIZER INC. | $3,650 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | DUAVEE Drug, GENITOURINARY (SEXUAL HEALTH);WOMENS HEALTH | 2023 |
The latest 200 records of 464.
Research payments naming this person as principal investigator
| Date | Company | Paid to | Amount | Study | Year |
|---|---|---|---|---|---|
| 2019-09-20 | AMAG Pharmaceuticals, Inc. | SUTTER EASY BAY HOSPITALS DBA | $500 | Prasterone DHEA for the Treatment of Hypoactive Sexual Desire Disorder HSDD - Placebo-Controlled, Double Blind and Rando | 2019 |
| 2019-09-09 | AMAG Pharmaceuticals, Inc. | SUTTER EASY BAY HOSPITALS DBA | $4,046 | Prasterone DHEA for the Treatment of Hypoactive Sexual Desire Disorder HSDD - Placebo-Controlled, Double Blind and Rando | 2019 |
| 2019-03-15 | AMAG Pharmaceuticals, Inc. | SUTTER EASY BAY HOSPITALS DBA | $1,341 | Prasterone DHEA for the Treatment of Hypoactive Sexual Desire Disorder HSDD - Placebo-Controlled, Double Blind and Rando | 2019 |
| 2019-02-28 | AMAG Pharmaceuticals, Inc. | SUTTER EASY BAY HOSPITALS DBA | $351 | Prasterone DHEA for the Treatment of Hypoactive Sexual Desire Disorder HSDD - Placebo-Controlled, Double Blind and Rando | 2019 |
| 2019-01-31 | AMAG Pharmaceuticals, Inc. | SUTTER EASY BAY HOSPITALS DBA | $3,034 | Prasterone DHEA for the Treatment of Hypoactive Sexual Desire Disorder HSDD - Placebo-Controlled, Double Blind and Rando | 2019 |
| 2019-01-31 | AMAG Pharmaceuticals, Inc. | SUTTER EASY BAY HOSPITALS DBA | $1,000 | Prasterone DHEA for the Treatment of Hypoactive Sexual Desire Disorder HSDD - Placebo-Controlled, Double Blind and Rando | 2019 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Berkeley, CA, county Alameda County, CA, state California; placed by its city name.
| Measure | Place (city or town) Berkeley, CA | County Alameda County, CA | State California |
|---|---|---|---|
| Population B01003 | 120,257 | 1,649,473 | 39,287,377 |
| Population, 2020 census P1 | 124,321 | 1,682,353 | 39,538,223 |
| Median age B01002 | 33.2 | 39.0 | 37.9 |
| Under 18 B01001 | 12.7% | 19.8% | 22.0% |
| 65 and over B01001 | 16.7% | 15.4% | 15.7% |
| Households B11001 | 47,135 | 598,246 | 13,548,091 |
| Foreign born B05002 | 21.1% | 34.7% | 27.0% |
| Median household income B19013 | $108,092 | $129,367 | $99,122 |
| Median family income B19113 | $202,712 | $159,585 | $113,346 |
| Per capita income B19301 | $69,534 | $65,862 | $49,513 |
| Poverty rate B17001 | 17.3% | 9.2% | 12.0% |
| Unemployment rate B23025 | 5.6% | 5.4% | 6.6% |
| Civilian labor force B23025 | 64,277 | 908,995 | 20,068,466 |
| Mean commute (minutes) B08013 | 27.8 | 31.0 | 28.7 |
| Bachelor's degree or higher B15003 | 74.9% | 52.2% | 37.1% |
| Housing units B25001 | 53,145 | 637,212 | 14,644,735 |
| Owner-occupied B25003 | 44.2% | 54.4% | 55.9% |
| Renters B25003 | 55.8% | 45.6% | 44.1% |
| Median home value B25077 | $1,413,900 | $1,090,100 | $734,700 |
| Median gross rent B25064 | $2,133 | $2,357 | $2,036 |
| White, not Hispanic B03002 | 49.9% | 27.4% | 33.8% |
| Black B03002 | 7.7% | 9.3% | 5.2% |
| Hispanic or Latino B03002 | 12.8% | 23.4% | 40.2% |
| Asian B03002 | 20.4% | 32.7% | 15.3% |
| American Indian and Alaska Native B03002 | 0.1% | 0.2% | 0.3% |
Economy now FRED unemployment 5.1% in Sep 2026 (5.5% a year earlier); per capita personal income $90,957 in 2025, up 30% in five years (+4.3% after inflation); the state; Source: FRED, Federal Reserve Bank of St. Louis.
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Berkeley, CA.
Comments